One-Year Frailty Transitions Among Persons With HIV Aged 70 Years or Older on Antiretroviral Treatment
Open Forum Infectious Diseases · 28.06.2024 · 11 (7)
DOI: 10.1093/ofid/ofae229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 26.04.2024. Verfasst von Jannett Achour und 11 weiteren Autor:innen. Beteiligte Einrichtung: INSERM CESP, U1018, Paris-Saclay University, Le Kremlin-Bicêtre, France. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANRS MIE, ViiVHealthcare, MSD, and Janssen.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
People with HIV (PWH) are aging. Frailty is an age-related condition predictive of hospitalization and mortality. Here, we assessed the frequency and factors associated with frailty transitions at 1-year follow-up in elderly PWH.
Methods
Five hundred eight PWH aged 70 years or older who were on antiretroviral treatment were included in the French multicenter SEPTAVIH study in 2019–2020. Participants were classified as robust, prefrail, or frail according to Fried frailty phenotype at baseline and at 1 year. Logistic regression models were used to evaluate socioeconomic and medical factors associated with transition between frailty states. Models were adjusted for gender, age at baseline, education, and period of HIV diagnosis (before vs after 1996).
Results
Seventeen PWH died during the 1-year follow-up. Of the remaining 491 PWH (median age, 73 years), frailty status worsened for 18% of participants and improved for 14% at 1 year. Advanced age, baseline CD4+ T-cell count <350 cells/mm3, and type 2 diabetes were associated with transition from prefrailty to frailty (adjusted odds ratio [aOR], 1.10 per 1-year positive difference; 95% CI, 1.01–1.20; aOR, 3.05; 95% CI, 1.14–8.18; and aOR, 2.63; 95% CI, 1.05–6.57; respectively). Being female was associated with more frequent improvement from prefrailty to robustness (aOR, 2.50; 95% CI, 1.09–5.55).
Conclusions
Preventing frailty in elderly PWH is a long-term problem, beginning with the early diagnosis of HIV infection and the management of comorbidities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- INSERM CESP, U1018, Paris-Saclay University, Le Kremlin-Bicêtre, France.
- Public Health Department, Bicêtre University Hospital, AP-HP, Le Kremlin-Bicêtre, France.
- Infectious Diseases Department, Montpellier University Hospital, Montpellier, France.
- Infectious Diseases Department, Rennes University Hospital, Rennes, France.
- Internal Medicine Department, Bordeaux University Hospital, Bordeaux, France.
- Internal Medicine Department, Bicêtre University Hospital, AP-HP, Le Kremlin-Bicêtre, France.
ORCID-Profile: Diane Abulizi, Laurence Slama, Hubert Blain
Förderung
- ANRS MIE
- ViiVHealthcare
- MSD, and Janssen
Zitieren
APA
Achour, J., Abulizi, D., Makinson, A., Arvieux, C., Bonnet, F., Goujard, C., Lambert, O., Slama, L., Blain, H., Meyer, L., Allavena, C., & SEPTAVIH Study Group (2024). One-Year Frailty Transitions Among Persons With HIV Aged 70 Years or Older on Antiretroviral Treatment. Open Forum Infectious Diseases, 11(7). https://doi.org/10.1093/ofid/ofae229
Vancouver
Achour J, Abulizi D, Makinson A, Arvieux C, Bonnet F, Goujard C, et al. One-Year Frailty Transitions Among Persons With HIV Aged 70 Years or Older on Antiretroviral Treatment. Open Forum Infectious Diseases. 2024;11(7). doi:10.1093/ofid/ofae229
BibTeX
@article{Achour2024,
author = {Achour, Jannett and Abulizi, Diane and Makinson, Alain and Arvieux, Cédric and Bonnet, Fabrice and Goujard, Cécile and Lambert, Oriane and Slama, Laurence and Blain, Hubert and Meyer, Laurence and Allavena, Clotilde and SEPTAVIH Study Group, SEPTAVIH Study Group},
title = {One-Year Frailty Transitions Among Persons With HIV Aged 70 Years or Older on Antiretroviral Treatment},
journal = {Open Forum Infectious Diseases},
year = {2024},
volume = {11},
number = {7},
doi = {10.1093/ofid/ofae229}
}
EUVIMED